In the current study, intragenic deletions were detected in two additional BHD families (BHD 57, 62), underlining the importance of MLPA or CGH analysis in patients with a clinical suspicion of BHD without an identifiable FLCN mutation. Here, FLCN is linked to Birt-Hogg-Dube syndrome.